IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

New U.S. Biosimilars Bill Gets Mixed Reviews

10:26 AM MDT | April 7, 2008 | Deepti Ramesh

A new House bill on biosimilars is drawing mixed reviews from industry. The Generic Pharmaceutical Association (GPhA; Arlington, VA) calls the Pathway for Biologics Act “a step backward” that puts brand company profits before patient needs, but the Biotechnology Industry Organization (BIO; Washington) says the bill is an important step forward toward follow-on biologics. Representatives Anna Eshoo (D., CA) and Joe Barton (R., TX) introduced the bill last month. Eshoo: Pathway to promote innovation. The bill provides 12 years of data exclusivity for...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa